SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 184.82-2.0%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dwc who wrote (16306)3/3/1998 12:03:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Here's the initial abstract on neu:

Nature 1984 Dec 6;312(5994):513-516

The neu oncogene: an erb-B-related gene encoding a
185,000-Mr tumour antigen.

Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg
RA

A series of rat neuro/glioblastomas all contain the same transforming gene (neu) which induces
synthesis of a tumour antigen of relative molecular mass (Mr) 185,000 (p185). The neu oncogene
bears homology to erb-B and the tumour antigen, p185, is serologically related to the epidermal
growth factor (EGF) receptor. The two proteins, EGF receptor and p185 appear to be distinct, as
they coexist in nontransformed Rat-1 cells.

PMID: 6095109, UI: 85061595
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext